The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
from The Scientist RSS https://ift.tt/Kf4s6ax
via
Thursday, March 31, 2022
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
Subscribe to:
Post Comments (Atom)
.png)
No comments: